Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

Abstract The COVID-19 pandemic has prompted an international effort to develop and repurpose medications and procedures to effectively combat the disease. Several groups have focused on the potential treatment utility of angiotensin-converting–enzyme inhibitors (ACEIs) and angiotensin...

Full description

Bibliographic Details
Main Authors: Bertsimas, Dimitris, Borenstein, Alison, Mingardi, Luca, Nohadani, Omid, Orfanoudaki, Agni, Stellato, Bartolomeo, Wiberg, Holly, Sarin, Pankaj, Varelmann, Dirk J., Estrada, Vicente, Macaya, Carlos, Gil, Iván J. N.
Other Authors: Sloan School of Management
Format: Article
Language:English
Published: Springer US 2021
Online Access:https://hdl.handle.net/1721.1/136841

Internet

https://hdl.handle.net/1721.1/136841

Similar Items